CLDX Historical PE Ratio image   This CLDX PE ratio history page last updated 8/19/2022
CLDX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/8/2022
37.47-0.77-3.08NA
Q1 2022
5/5/2022
30.34-0.49-1.96NA
Q4 2021
2/28/2022
29.90-0.43-1.72NA
Q3 2021
11/9/2021
45.91-0.37-1.48NA
Q2 2021
8/5/2021
47.70-0.34-1.36NA
Q1 2021
5/6/2021
26.57-0.42-1.68NA
Q4 2020
3/29/2021
20.47-0.55-2.20NA
Q3 2020
11/5/2020
17.82-0.36-1.44NA
Q2 2020
8/6/2020
11.71-0.50-2.00NA
Q1 2020
5/6/2020
2.39-0.73-2.92NA
Q4 2019
3/26/2020
1.79-0.64-2.56NA
Q3 2019
11/12/2019
2.29-0.75-3.00NA
Q2 2019
8/7/2019
2.16-0.84-3.36NA
Q1 2019
5/7/2019
3.84-1.40-5.60NA
Q4 2018
3/7/2019
4.60-0.81-3.24NA
Q3 2018
11/7/2018
5.10-0.60-2.40NA
Q2 2018
8/8/2018
7.20-1.65-6.60NA
Q1 2018
5/10/2018
10.80-12.75-51.00NA
Q4 2017
3/7/2018
37.05-2.55-10.20NA
Q3 2017
11/7/2017
39.30-2.10-8.40NA
Q2 2017
8/8/2017
38.40-3.45-13.80NA
Q1 2017
5/9/2017
47.40-4.20-16.80NA
Q4 2016
3/14/2017
49.50-4.50-18.00NA
Q3 2016
11/7/2016
49.35-4.35-17.40NA
Q2 2016
8/8/2016
67.80-4.80-19.20NA
Q1 2016
5/5/2016
52.35-5.25-21.00NA
Q4 2015
2/25/2016
103.65-4.95-19.80NA
Q3 2015
11/5/2015
187.65-4.80-19.20NA
Q2 2015
8/10/2015
320.25-4.95-19.80NA
Q1 2015
4/29/2015
368.10-4.95-19.80NA
Q4 2014
2/24/2015
381.90-5.40-21.60NA
Q3 2014
11/4/2014
248.70-4.65-18.60NA
Q2 2014
8/6/2014
199.50-4.80-19.20NA
Q1 2014
5/1/2014
219.60-4.95-19.80NA
Q4 2013
3/3/2014
394.20-4.05-16.20NA
Q3 2013
11/8/2013
384.75-4.35-17.40NA
Q2 2013
8/6/2013
305.40-3.60-14.40NA
Q1 2013
5/2/2013
187.05-3.45-13.80NA
Q4 2012
3/7/2013
157.35-4.05-16.20NA
Q3 2012
11/1/2012
84.00-3.75-15.00NA
Q2 2012
8/10/2012
68.40-3.45-13.80NA
Q1 2012
5/3/2012
60.45-4.05-16.20NA
CLDX PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/8/2022
37.47-0.77-2.06NA
Q1 2022
5/5/2022
30.34-0.49-1.63NA
Q4 2021
2/28/2022
29.90-0.43-1.56NA
Q3 2021
11/9/2021
45.91-0.37-1.68NA
Q2 2021
8/5/2021
47.70-0.34-1.67NA
Q1 2021
5/6/2021
26.57-0.42-1.83NA
Q4 2020
3/29/2021
20.47-0.55-2.14NA
Q3 2020
11/5/2020
17.82-0.36-2.23NA
Q2 2020
8/6/2020
11.71-0.50-2.62NA
Q1 2020
5/6/2020
2.39-0.73-2.96NA
Q4 2019
3/26/2020
1.79-0.64-3.63NA
Q3 2019
11/12/2019
2.29-0.75-3.80NA
Q2 2019
8/7/2019
2.16-0.84-3.65NA
Q1 2019
5/7/2019
3.84-1.40-4.46NA
Q4 2018
3/7/2019
4.60-0.81-15.81NA
Q3 2018
11/7/2018
5.10-0.60-17.55NA
Q2 2018
8/8/2018
7.20-1.65-19.05NA
Q1 2018
5/10/2018
10.80-12.75-20.85NA
Q4 2017
3/7/2018
37.05-2.55-12.30NA
Q3 2017
11/7/2017
39.30-2.10-14.25NA
Q2 2017
8/8/2017
38.40-3.45-16.50NA
Q1 2017
5/9/2017
47.40-4.20-17.85NA
Q4 2016
3/14/2017
49.50-4.50-18.90NA
Q3 2016
11/7/2016
49.35-4.35-19.35NA
Q2 2016
8/8/2016
67.80-4.80-19.80NA
Q1 2016
5/5/2016
52.35-5.25-19.95NA
Q4 2015
2/25/2016
103.65-4.95-19.65NA
Q3 2015
11/5/2015
187.65-4.80-20.10NA
Q2 2015
8/10/2015
320.25-4.95-19.95NA
Q1 2015
4/29/2015
368.10-4.95-19.80NA
Q4 2014
2/24/2015
381.90-5.40-19.80NA
Q3 2014
11/4/2014
248.70-4.65-18.45NA
Q2 2014
8/6/2014
199.50-4.80-18.15NA
Q1 2014
5/1/2014
219.60-4.95-16.95NA
Q4 2013
3/3/2014
394.20-4.05-15.45NA
Q3 2013
11/8/2013
384.75-4.35-15.45NA
Q2 2013
8/6/2013
305.40-3.60-14.85NA
Q1 2013
5/2/2013
187.05-3.45-14.70NA
Q4 2012
3/7/2013
157.35-4.05-15.30NA
Q3 2012
11/1/2012
84.00-3.75NANA
Q2 2012
8/10/2012
68.40-3.45NANA
Q1 2012
5/3/2012
60.45-4.05NANA
Quotes delayed 20 minutes

Email EnvelopeFree CLDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Celldex Therapeutics (CLDX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CLNN PE Ratio History
CLOV PE Ratio History
CLPT PE Ratio History
CLRB PE Ratio History
CLSD PE Ratio History
CLSN PE Ratio History
CLVS PE Ratio History
CLXT PE Ratio History
CMAX PE Ratio History
CMD PE Ratio History
How should the CLDX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Celldex Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CLDX Historical PE Ratio page.

What is the average historical PE for CLDX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CLDX historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for CLDX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CLDX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the CLDX Historical PE Ratio information for Celldex Therapeutics' stock. The average CLDX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CLDX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CLDX historical PE result, against the recent PE: when this page was posted on 8/18/2022, the most recent closing price for CLDX had been 34.20, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on CLDX or any other given stock, valuation analysis for CLDX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Celldex Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CLDX. Thanks for visiting, and the next time you need to research CLDX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding PQIN, Cigna YTD Return, PES Options Chain.

 

CLDX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.